PBS Pharmaceuticals in Hospitals Review
Page last updated: 20 May 2019
The Pharmaceutical Reform Agreements (PRAs) support the access of PBS medicines in the public hospital setting. These agreements are in place between the Commonwealth and all jurisdictions except New South Wales and the Australian Capital Territory. The PRAs enable approved public hospitals to prescribe and dispense PBS-subsidised medicines, chemotherapy drugs and highly specialised drugs to day-admitted patients, outpatients, and patients upon discharge.
The PBS Pharmaceuticals in Hospitals Review (the Review) provides insight and understanding as to how the PBS and its sub-programs are used in the supply of PBS medicines in public and private hospitals in Australia. The Review describes and profiles the various arrangements used to procure, purchase, prescribe and dispense PBS medicines in public and private hospitals. It also reports on operational issues faced by states and territories and private hospital operators.
- PBS Pharmaceuticals in Hospitals Review Report (PDF 3.1MB)
- PBS Pharmaceuticals in Hospitals Review Report (Word 3.7MB)
